Frontier Capital Management CO LLC Karyopharm Therapeutics Inc. Transaction History

Frontier Capital Management CO LLC

$9.96 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $13,676 - $19,508	-3,352 Reduced 0.53%	629,154 $3.44 Million
Q2 2022 Jul 20, 2022	SELL	$4.15 - $8.37 $2.68 Million - $5.41 Million	-646,789 Reduced 50.56%	632,506 $2.85 Million
Q1 2022 Apr 14, 2022	SELL	$5.91 - $14.38 $2.4 Million - $5.84 Million	-406,110 Reduced 24.1%	1,279,295 $9.43 Million
Q4 2021 Jan 19, 2022	BUY	$5.21 - $8.61 $3.04 Million - $5.02 Million	582,978 Added 52.88%	1,685,405 $10.8 Million
Q3 2021 Oct 19, 2021	SELL	$4.45 - $10.63 $1.72 Million - $4.11 Million	-386,512 Reduced 25.96%	1,102,427 $6.42 Million
Q2 2021 Aug 09, 2021	BUY	$8.11 - $11.11 $2.17 Million - $2.97 Million	267,312 Added 21.88%	1,488,939 $15.4 Million
Q1 2021 May 13, 2021	SELL	$9.85 - $17.69 $18.8 Million - $33.7 Million	-1,905,944 Reduced 60.94%	1,221,627 $12.9 Million
Q4 2020 Jan 19, 2021	SELL	$14.15 - $17.19 $8.15 Million - $9.91 Million	-576,215 Reduced 15.56%	3,127,571 $48.4 Million
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $12.9 Million - $18 Million	913,285 Added 32.73%	3,703,786 $54.1 Million
Q2 2020 Jul 17, 2020	BUY	$16.6 - $25.25 $15.8 Million - $24 Million	951,061 Added 51.7%	2,790,501 $52.9 Million
Q1 2020 Apr 16, 2020	BUY	$14.38 - $27.72 $11.8 Million - $22.7 Million	820,302 Added 80.49%	1,839,440 $35.3 Million
Q4 2019 Feb 14, 2020	SELL	$9.23 - $19.67 $6.98 Million - $14.9 Million	-756,727 Reduced 42.61%	1,019,138 $19.5 Million
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $6.19 Million - $13 Million	1,093,012 Added 160.07%	1,775,865 $17.1 Million
Q2 2019 Aug 14, 2019	SELL	$4.32 - $6.43 $2,203 - $3,279	-510 Reduced 0.07%	682,853 $4.09 Million
Q1 2019 May 07, 2019	BUY	$4.12 - $10.25 $2.13 Million - $5.3 Million	517,464 Added 311.92%	683,363 $3.99 Million
Q4 2018 Jan 25, 2019	SELL	$8.2 - $16.95 $316,987 - $655,236	-38,657 Reduced 18.9%	165,899 $1.55 Million
Q3 2018 Oct 30, 2018	SELL	$17.03 - $21.18 $1.75 Million - $2.17 Million	-102,479 Reduced 33.38%	204,556 $3.48 Million
Q2 2018 Aug 03, 2018	BUY	$12.0 - $19.88 $3.68 Million - $6.1 Million	307,035 New	307,035 $5.22 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.55 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.27 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.76 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.67 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account